Skip to content

Clinical trials

Phase 1 Disorders of Excessive Somnolence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Phase: Phase 1 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20141
20191
20202
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axsome Therapeutics, Inc.1
Brigham and Women's Hospital1
Centessa Pharmaceuticals (UK) Limited1
Concert Pharmaceuticals1
Emory University1
Expansion Therapeutics, Inc.1
Syndeio Biosciences, Inc1
University of Basel1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence8
Narcolepsy3
Brain Injuries, Traumatic1
Kidney Diseases1
Kidney Failure, Chronic1
Major Depressive Disorder1
Myotonic Dystrophy1
Sleep Apnea, Obstructive1
Sleep Initiation and Maintenance Disorders1
Sleep Wake Disorders1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.